These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7486645)

  • 21. Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids.
    Sinha B; Semmler J; Eisenhut T; Eigler A; Endres S
    Eur J Immunol; 1995 Jan; 25(1):147-53. PubMed ID: 7843225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of tumour necrosis factor production by adrenal hormones in vivo: insights into the antiinflammatory activity of rolipram.
    Pettipher ER; Labasi JM; Salter ED; Stam EJ; Cheng JB; Griffiths RJ
    Br J Pharmacol; 1996 Apr; 117(7):1530-4. PubMed ID: 8730750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SB 207499 (Ariflo), a second generation phosphodiesterase 4 inhibitor, reduces tumor necrosis factor alpha and interleukin-4 production in vivo.
    Griswold DE; Webb EF; Badger AM; Gorycki PD; Levandoski PA; Barnette MA; Grous M; Christensen S; Torphy TJ
    J Pharmacol Exp Ther; 1998 Nov; 287(2):705-11. PubMed ID: 9808700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of inhibitors of phosphodiesterase, on antigen-induced bronchial hyperreactivity in conscious sensitized guinea-pigs and airway leukocyte infiltration.
    Danahay H; Broadley KJ
    Br J Pharmacol; 1997 Jan; 120(2):289-97. PubMed ID: 9117122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of inhibition of PDE4 and TNF-alpha on local and remote injuries following ischaemia and reperfusion injury.
    Souza DG; Cassali GD; Poole S; Teixeira MM
    Br J Pharmacol; 2001 Nov; 134(5):985-94. PubMed ID: 11682446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNF alpha generation from human monocytes by interacting with a 'low-affinity' phosphodiesterase 4 conformer.
    Souness JE; Griffin M; Maslen C; Ebsworth K; Scott LC; Pollock K; Palfreyman MN; Karlsson JA
    Br J Pharmacol; 1996 Jun; 118(3):649-58. PubMed ID: 8762090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Striking effect of hydroxamic acid substitution on the phosphodiesterase type 4 (PDE4) and TNF alpha inhibitory activity of two series of rolipram analogues: implications for a new active site model of PDE4.
    Kleinman EF; Campbell E; Giordano LA; Cohan VL; Jenkinson TH; Cheng JB; Shirley JT; Pettipher ER; Salter ED; Hibbs TA; DiCapua FM; Bordner J
    J Med Chem; 1998 Jan; 41(3):266-70. PubMed ID: 9464356
    [No Abstract]   [Full Text] [Related]  

  • 28. Phosphodiesterase IV inhibitors as therapy for eosinophil-induced lung injury in asthma.
    Torphy TJ; Barnette MS; Hay DW; Underwood DC
    Environ Health Perspect; 1994 Dec; 102 Suppl 10(Suppl 10):79-84. PubMed ID: 7705312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood mononuclear cell production of TNF-alpha and IL-8: engagement of different signal transduction pathways including the p42 MAP kinase pathway.
    Foreback JL; Sarma V; Yeager NR; Younkin EM; Remick DG; Ward PA
    J Leukoc Biol; 1998 Jul; 64(1):124-33. PubMed ID: 9665286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The inhibitory effect of rolipram on TNF-alpha production in mouse blood ex vivo is dependent upon the release of corticosterone and adrenaline.
    Pettipher ER; Eskra JD; Labasi JM
    Cytokine; 1997 Aug; 9(8):582-6. PubMed ID: 9245486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of TNF-alpha production in human mononuclear cells by an adenosine kinase inhibitor.
    Eigler A; Matschke V; Hartmann G; Erhardt S; Boyle D; Firestein GS; Endres S
    J Leukoc Biol; 2000 Jul; 68(1):97-103. PubMed ID: 10914495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rolipram, a phosphodiesterase inhibitor, in the treatment of two male patients with congenital nephrogenic diabetes insipidus.
    Bichet DG; Ruel N; Arthus MF; Lonergan M
    Nephron; 1990; 56(4):449-50. PubMed ID: 1964202
    [No Abstract]   [Full Text] [Related]  

  • 33. Varied actions of proinflammatory cytokines on excitotoxic cell death in the rat central nervous system.
    Allan SM
    J Neurosci Res; 2002 Feb; 67(4):428-34. PubMed ID: 11835309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain TNF: damage limitation or damaged reputation?
    Rothwell NJ; Luheshi GN
    Nat Med; 1996 Jul; 2(7):746-7. PubMed ID: 8673916
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthesis of tumour necrosis factor-alpha in tissue culture of rat caecum: lack of suppression by phosphodiesterase inhibitors and prostanoids.
    Greten TF; Moeller J; Feldmeier H; Eigler A; Endres S
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):679-84. PubMed ID: 8853258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor necrosis factor-alpha induces early-onset endothelial adhesivity by protein kinase Czeta-dependent activation of intercellular adhesion molecule-1.
    Javaid K; Rahman A; Anwar KN; Frey RS; Minshall RD; Malik AB
    Circ Res; 2003 May; 92(10):1089-97. PubMed ID: 12714560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein kinase c-dependent pathway is critical for the production of pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6).
    Kontny E; Ziółkowska M; Ryzewska A; Maśliński W
    Cytokine; 1999 Nov; 11(11):839-48. PubMed ID: 10547271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rolipram: antidepressant used in Europe and Japan might have promise against TNF, HIV.
    Smith D
    AIDS Treat News; 1996 Mar; (no 242):3-4. PubMed ID: 11363192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha.
    Feuerstein GZ; Liu T; Barone FC
    Cerebrovasc Brain Metab Rev; 1994; 6(4):341-60. PubMed ID: 7880718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Action of cAMP on expression and release of adhesion molecules in human endothelial cells.
    Morandini R; Ghanem G; Portier-Lemarié A; Robaye B; Renaud A; Boeynaems JM
    Am J Physiol; 1996 Mar; 270(3 Pt 2):H807-16. PubMed ID: 8780174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.